Arcadia Biosciences, Inc.
RKDA- Exchange
- Nasdaq
- Industry
- Crude Petroleum & Natural Gas
- SEC CIK
- 0001469443
No open-market purchases or sales by Arcadia Biosciences, Inc. insiders were filed in the last 90 days; 18 institutions reported holding it in 13F filings for Q2 2026, worth $146.5K in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Arcadia Biosciences, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 27 | 21 | −6 |
| Shares | 2.49M | 3.16M | +669.3K (+26.8%) |
| Value | $7.40M | $6.54M | −$858.0K (−11.6%) |
New holders (2)
Institutions that held Arcadia Biosciences, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 213,502 | $442.0K | 0.00% |
| Cutler Group LP | 400 | $0 | 0.00% |
Sold out (8)
Institutions that held Arcadia Biosciences, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Boothbay Fund Management, LLC | 50,294 | $149.0K |
| Goldman Sachs Group Inc | 31,666 | $94.0K |
| Jane Street Group, LLC | 19,525 | $58.0K |
| Two Sigma Securities, LLC | 10,917 | $32.0K |
| Pinz Capital Management, LP | 8,000 | $24.0K |
| Gemmer Asset Management LLC | 1,200 | $4.00K |
| Royal Bank of Canada | 561 | $1.00K |
| Bank of America Corp | 53 | $0 |